Breakthrough Lung Cancer Drug Holds New Promise for Patients with Advanced-stage Disease - Carolinas HealthCare System’s Levine Cancer Institute was featured in the New England Journal of Medicine for its prominent role in research that advances the treatment of advanced-stage lung cancer. Daniel Haggstrom, MD, is a medical oncologist at the Institute and co-author of the study, which demonstrated the efficacy of a molecular-targeted therapy, AZD9291, in patients with advanced-stage lung cancer. READ MORE
Hematologic Oncology Translational (HOT) Laboratory The major focus of the HOT laboratory is to clarify basic mechanisms regulating normal and cancerous blood cell production, and use this information to develop novel methods for predicting cancer relapse and treatment strategies that improve survival for patients with hematologic malignancies.
Translational Research and Cancer Pharmacology in Hematological Malignancies Tumor genes are complex and significantly impact the way we establish new cancer treatments. The goal of the Cancer Pharmacology Department at Levine Cancer Institute is to support research for developing new treatments for cancer by moving ideas from the laboratory to the clinic (known as translational research).